Pharming Group N.V. (PHAR) Non-Current Assets (2019 - 2024)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Pharming (PHAR) has disclosed Non-Current Assets for 6 consecutive years, with $121.5 million as the latest value for Q4 2024.

• For the quarter ending Q4 2024, Non-Current Assets fell 17.04% year-over-year to $121.5 million, compared with a TTM value of $121.5 million through Dec 2024, down 17.04%, and an annual FY2024 reading of $121.5 million, down 17.04% over the prior year.
• Non-Current Assets was $121.5 million for Q4 2024 at Pharming, down from $146.5 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $150.7 million in Q4 2020 and bottomed at $121.5 million in Q4 2024.
• Average Non-Current Assets over 5 years is $143.0 million, with a median of $147.9 million recorded in 2021.
• The sharpest move saw Non-Current Assets grew 11.88% in 2020, then dropped 17.04% in 2024.
• Year by year, Non-Current Assets stood at $150.7 million in 2020, then decreased by 1.89% to $147.9 million in 2021, then increased by 0.29% to $148.3 million in 2022, then fell by 1.2% to $146.5 million in 2023, then dropped by 17.04% to $121.5 million in 2024.
• Business Quant data shows Non-Current Assets for PHAR at $121.5 million in Q4 2024, $146.5 million in Q4 2023, and $148.3 million in Q4 2022.

Peer Comparison